SOX9 Human shRNA Plasmid Kit (Locus ID 6662)
CAT#: TL309170
SOX9 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
Cited in 2 publications. |
CNY 1,999.00
CNY 2,700.00
CNY 4,070.00
Specifications
Product Data | |
Product Name | SOX9 Human shRNA Plasmid Kit (Locus ID 6662) |
Locus ID | 6662 |
UniProt ID | P48436 |
Synonyms | CMD1; CMPD1; SRA1; SRXX2; SRXY10 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | SOX9 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 6662). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_000346, NM_000346.1, NM_000346.2, NM_000346.3, BC056420, BC056420.1, BC007951, BC018276, NM_000346.4 |
Summary | The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Incomplete radiofrequency ablation promotes the development of CD133+ cancer stem cells in hepatocellular carcinoma cell line HepG2 via inducing SOX9 expression
,Yuan, CW;Wang, ZC;Liu, K;Liu, DJ;,
HBPD INT
,PubMed ID 30262419
[SOX9]
|
SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas
,Kim, AL;Back, JH;Chaudhary, SC;Zhu, Y;Athar, M;Bickers, DR;,
J. Invest. Dermatol.
,PubMed ID 29550418
[SOX9]
|
Documents
Product Manuals |
FAQs |
SDS |